U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H6Br2O
Molecular Weight 277.941
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of P-BROMOPHENACYL BROMIDE

SMILES

BrCC(=O)C1=CC=C(Br)C=C1

InChI

InChIKey=FKJSFKCZZIXQIP-UHFFFAOYSA-N
InChI=1S/C8H6Br2O/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4H,5H2

HIDE SMILES / InChI

Molecular Formula C8H6Br2O
Molecular Weight 277.941
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Purification, characterization, and cDNA cloning of acidic platelet aggregation inhibiting phospholipases A(2) from the snake venom of Vipera lebetina (Levantine viper).
2009-09-15
Purification and characterization of the biological effects of phospholipase A(2) from sea anemone Bunodosoma caissarum.
2009-09-15
Nitric oxide-induced membrane tubulovesicular extensions (cytonemes) of human neutrophils catch and hold Salmonella enterica serovar Typhimurium at a distance from the cell surface.
2009-07
MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration.
2009-05
Catalytic activity-independent pathway is involved in phospholipase A(2)-induced apoptotic death of human leukemia U937 cells via Ca(2+)-mediated p38 MAPK activation and mitochondrial depolarization.
2009-03-10
Hemolytic and anticoagulant study of the neurotoxin vipoxin and its components--basic phospholipase A2 and an acidic inhibitor.
2009-03
Fast quantitative determination of microbial rhamnolipids from cultivation broths by ATR-FTIR Spectroscopy.
2008-10-07
Involvement of cPLA2 inhibition in dexamethasone-induced thymocyte apoptosis.
2008-10-04
p38 MAPK activation and mitochondrial depolarization mediate the cytotoxicity of Taiwan cobra phospholipase A2 on human neuroblastoma SK-N-SH cells.
2008-07-30
Phospholipase A2 activation enhances inhibitory synaptic transmission in rat substantia gelatinosa neurons.
2008-03
Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
2008-03
Phospholipase A2-like activity of human bocavirus VP1 unique region.
2008-01-04
Design of a modern liposome and bee venom formulation for the traditional VIT-venom immunotherapy.
2008
Phospholipase A2beta mediates light-induced stomatal opening in Arabidopsis.
2008
Secretory phospholipase A2-alpha from Arabidopsis thaliana: functional parameters and substrate preference.
2007-12
Role of phospholipase A2 (group I secreted) in the genesis of basal tone in the internal anal sphincter smooth muscle.
2007-11
Lysophosphatidylcholine produced by the phospholipase A2 isolated from Lachesis muta snake venom modulates natural killer activity as a protein kinase C effector.
2007-09-01
Purification and characterization of 45 kDa PAF acetylhydrolase from bovine colostrum.
2007-09
Production of medium-chain-length hydroxyalkanoic acids from Pseudomonas putida in pH stat.
2007-07
Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea.
2007-01
Preliminary X-ray crystallographic studies of a Lys49-phospholipase A2 homologue from Bothrops pirajai venom complexed with p-bromo-phenacyl bromide and alpha-tocopherol inhibitors.
2007
Precolumn derivatization of cysteine residues for quantitative analysis of five major cytochrome P450 isoenzymes by liquid chromatography/tandem mass spectrometry.
2007
Bile acid analysis in biliary tract cancer.
2006-12-31
Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts.
2006-12
Bromophenacyl bromide, a phospholipase A2 inhibitor attenuates chemically induced gastroduodenal ulcers in rats.
2006-09-28
BE-I-PLA2, a novel acidic phospholipase A2 from Bothrops erythromelas venom: isolation, cloning and characterization as potent anti-platelet and inductor of prostaglandin I2 release by endothelial cells.
2006-07-28
Crystallization and preliminary X-ray diffraction analysis of a myotoxic Lys49-PLA2 from Bothrops jararacussu venom complexed with p-bromophenacyl bromide.
2006-06-01
A neurotoxic phospholipase A2 variant: isolation and characterization from eastern regional Indian cobra (Naja naja) venom.
2006-06-01
Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid.
2006-06
Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution.
2006-05-03
Apoptosis-inducing factor of a cytotoxic T cell line: involvement of a secretory phospholipase A2.
2006-05
Structure of BthA-I complexed with p-bromophenacyl bromide: possible correlations with lack of pharmacological activity.
2005-12
Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan Taipan (Oxyuranus scutellatus canni).
2005-12
A secretory PLA2 associated with tobacco hornworm hemocyte membrane preparations acts in cellular immune reactions.
2005-11
The human red cell voltage-dependent cation channel. Part III: Distribution homogeneity and pH dependence.
2005-10-01
Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins.
2005-09-22
Protection of rats against 3-butene-1,2-diol-induced hepatotoxicity and hypoglycemia by N-acetyl-l-cysteine.
2005-09-15
Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom.
2005-09-15
HPLC determination of salinomycin and related compounds in fermentation media of Streptomyces albus and premixes.
2005-09-15
Activation of calcium-independent phospholipase A (iPLA) in brain mitochondria and release of apoptogenic factors by BAX and truncated BID.
2005-08
Phospholipase A2-dependent effects of the venom from the New Guinean small-eyed snake Micropechis ikaheka.
2005-07
Scanning electron microscopy study of neutrophil membrane tubulovesicular extensions (cytonemes) and their role in anchoring, aggregation and phagocytosis. The effect of nitric oxide.
2005-04-01
G-protein coupled activation of potassium channels by endogenous neuropeptides in snail neurons.
2005-04
Xanthine oxidase, nitric oxide synthase and phospholipase A(2) produce reactive oxygen species via mitochondria.
2005-03-10
Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: role of catalytic activity.
2005-03-01
Biological and enzymatic activities of Micrurus sp. (Coral) snake venoms.
2005-01
Phospholipase A2 activation by melittin enhances spontaneous glutamatergic excitatory transmission in rat substantia gelatinosa neurons.
2005
Para-Bromophenacyl bromide alleviates airway hyperresponsiveness and modulates cytokines, IgE and eosinophil levels in ovalbumin-sensitized and -challenged mice.
2004-12-15
Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
2004-07
p-Bromophenacyl bromide prevents cumene hydroperoxide-induced mitochondrial permeability transition by inhibiting pyridine nucleotide oxidation.
2004
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 19:15:12 GMT 2025
Edited
by admin
on Mon Mar 31 19:15:12 GMT 2025
Record UNII
PN0FRW1G4Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
P-BROMOPHENACYL BROMIDE
MI  
Common Name English
NSC-6224
Preferred Name English
2,4'-DIBROMOACETOPHENONE
Systematic Name English
P,.ALPHA.-DIBROMOACETOPHENONE
Common Name English
P-BROMOPHENACYL BROMIDE [MI]
Common Name English
2-BROMO-1-(4-BROMOPHENYL)ETHANONE
Systematic Name English
4-BROMOPHENACYL BROMIDE
Systematic Name English
BROMOPHENACYL BROMIDE, 4-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID4059201
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY
NSC
6224
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY
CAS
99-73-0
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY
FDA UNII
PN0FRW1G4Z
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY
ECHA (EC/EINECS)
202-783-6
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY
MESH
C006821
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY
PUBCHEM
7454
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY
MERCK INDEX
m2708
Created by admin on Mon Mar 31 19:15:12 GMT 2025 , Edited by admin on Mon Mar 31 19:15:12 GMT 2025
PRIMARY Merck Index